NCT06994299 2025-11-18
PRISM
Weill Medical College of Cornell University
Phase 2 Withdrawn
Clinical Trials
24 trialsNCT06670976 2025-08-26
Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma
Roswell Park Cancer Institute
Phase 1 Withdrawn
NCT05296005 2025-02-07
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
Ohio State University Comprehensive Cancer Center
Phase 1 Withdrawn
NCT06328036 2024-12-30
Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT02428764 2024-12-10
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
Sun Yat-sen University
Phase 2 Withdrawn
NCT04231526 2024-07-31
Pembrolizumab in Early Stage Colon Cancer
University of Chicago
Phase 2 Withdrawn
NCT03179449 2023-04-14
In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI
Stanford University
Phase EARLY_PHASE1 Withdrawn
NCT03199144 2022-06-23
CKPancreas
Centre Francois Baclesse, Luxembourg
Phase 2 Withdrawn
NCT02272699 2021-03-18
Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma
Peking University
Phase 2/3 Withdrawn
NCT03718650 2021-02-08
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Withdrawn
NCT03575234 2019-08-28
Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer
Emory University
Phase 1 Withdrawn
NCT03480867 2019-08-14
PARADIGMA
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 1 Withdrawn
NCT03307941 2017-12-19
ARTEMIS-Eso
Jules Bordet Institute
Phase 1/2 Withdrawn
NCT00855114 2017-12-02
Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
Masonic Cancer Center, University of Minnesota
Phase 2 Withdrawn
NCT01646554 2017-05-09
BOS3
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Withdrawn
NCT02061007 2016-05-09
Biomarker Correlates of Hypoxia in Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn
NCT02598687 2016-04-21
Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.
Maastricht Radiation Oncology
Phase 1 Withdrawn
NCT01169129 2014-02-04
Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases
Barretos Cancer Hospital
Phase 3 Withdrawn
NCT00080613 2013-07-10
Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00017160 2013-06-27
Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
Radiation Therapy Oncology Group
Phase 2 Withdrawn
NCT01295970 2013-06-13
Surgery Versus Radiosurgery for the Treatment of Single Brain Metastases
University Health Network, Toronto
Phase NA Withdrawn
NCT00238160 2013-05-30
Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer
National Cancer Institute (NCI)
Phase 3 Withdrawn
NCT00487851 2013-04-12
Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer
Karolinska Institutet
Phase 2 Withdrawn
NCT00725400 2011-07-20
Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma
American Scitech International
Phase 2 Withdrawn